Fraunhofer Institute for Cell Therapy and Immunology (IZI), Branch Bioanalytics and Bioprocesses (IZI-BB), Am Mühlenberg 13, 14476 Potsdam, Germany.
Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam, Germany.
Int J Mol Sci. 2023 Feb 1;24(3):2808. doi: 10.3390/ijms24032808.
G protein-coupled receptors (GPCRs) are of outstanding pharmacological interest as they are abundant in cell membranes where they perform diverse functions that are closely related to the vitality of cells. The analysis of GPCRs in natural membranes is laborious, as established methods are almost exclusively cell culture-based and only a few methods for immobilization in a natural membrane outside the cell are known. Within this study, we present a one-step, fast and robust immobilization strategy of the GPCR glucagon-like peptide 1 receptor (GLP-1R). GLP-1R was synthesized in eukaryotic lysates harboring endogenous endoplasmic reticulum-derived microsomes enabling the embedment of GLP-1R in a natural membrane. Interestingly, we found that these microsomes spontaneously adsorbed to magnetic Neutravidin beads thus providing immobilized membrane protein preparations which required no additional manipulation of the target receptor or its supporting membrane. The accessibility of the extracellular domain of membrane-embedded and bead-immobilized GLP-1R was demonstrated by bead-based enzyme-linked immunosorbent assay (ELISA) using GLP-1R-specific monoclonal antibodies. In addition, ligand binding of immobilized GLP-1R was verified in a radioligand binding assay. In summary, we present an easy and straightforward synthesis and immobilization methodology of an active GPCR which can be beneficial for studying membrane proteins in general.
G 蛋白偶联受体(GPCRs)具有重要的药理学意义,因为它们在细胞膜中大量存在,在那里它们执行着与细胞活力密切相关的多种功能。在天然膜中分析 GPCRs 是费力的,因为已建立的方法几乎完全基于细胞培养,并且仅知道少数几种在细胞外的天然膜中固定的方法。在本研究中,我们提出了一种一步、快速且稳健的 GPCR 胰高血糖素样肽 1 受体(GLP-1R)固定化策略。GLP-1R 在含有内源性内质网衍生的微粒体的真核细胞裂解物中合成,使 GLP-1R 嵌入天然膜中。有趣的是,我们发现这些微粒体自发地吸附到磁性链霉亲和素珠上,从而提供了无需对靶受体或其支持膜进行额外操作的固定化膜蛋白制剂。通过使用 GLP-1R 特异性单克隆抗体的基于珠的酶联免疫吸附测定(ELISA),证明了膜嵌入和珠固定化的 GLP-1R 的细胞外结构域的可及性。此外,通过放射性配体结合测定验证了固定化 GLP-1R 的配体结合。总之,我们提出了一种简单直接的活性 GPCR 的合成和固定化方法,这对于研究一般的膜蛋白可能是有益的。